Romiplostim in Combination With CsA vs. CsA in the Treatment of Newly Diagnosed NSAA
Condition(s):Non Severe Aplastic AnemiaLast Updated:August 24, 2023Not yet recruiting
Include Studies Not Open or Pending
Condition(s):Non Severe Aplastic AnemiaLast Updated:August 24, 2023Not yet recruiting
Condition(s):Chemotherapy-induced ThrombocytopeniaLast Updated:March 7, 2024Recruiting
Condition(s):Primary Immune ThrombocytopeniaLast Updated:March 18, 2024Recruiting
Condition(s):Chemotherapy-induced Thrombocytopenia; Solid MalignancyLast Updated:January 11, 2024Recruiting
Condition(s):Pharmacodynamics; Pharmacokinetics; BioequivalenceLast Updated:December 15, 2022Recruiting
Condition(s):Immune Thrombocytopenia PurpuraLast Updated:May 16, 2023Recruiting
Condition(s):Thrombocytopenia; Drugs; Chronic Liver DiseaseLast Updated:November 15, 2022Recruiting
Condition(s):ITP – Immune ThrombocytopeniaLast Updated:November 18, 2023Not yet recruiting
Condition(s):ITP – Immune ThrombocytopeniaLast Updated:November 14, 2023Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.